Cargando…

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker

INTRODUCTION: CKD273 is a urinary biomarker, which in advanced chronic kidney disease predicts further deterioration. We investigated whether CKD273 can also predict a decline of estimated glomerular filtration rate (eGFR) to <60 ml/min per 1.73 m(2). METHODS: In analyses of 2087 individuals from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pontillo, Claudia, Zhang, Zhen-Yu, Schanstra, Joost P., Jacobs, Lotte, Zürbig, Petra, Thijs, Lutgarde, Ramírez-Torres, Adela, Heerspink, Hiddo J.L., Lindhardt, Morten, Klein, Ronald, Orchard, Trevor, Porta, Massimo, Bilous, Rudolf W., Charturvedi, Nishi, Rossing, Peter, Vlahou, Antonia, Schepers, Eva, Glorieux, Griet, Mullen, William, Delles, Christian, Verhamme, Peter, Vanholder, Raymond, Staessen, Jan A., Mischak, Harald, Jankowski, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669285/ https://www.ncbi.nlm.nih.gov/pubmed/29130072 http://dx.doi.org/10.1016/j.ekir.2017.06.004

Ejemplares similares

Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease
por: Pontillo, Claudia, et al.
Publicado: (2017)

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study
por: Jaimes Campos, Mayra Alejandra, et al.
Publicado: (2023)

Glycosylation Analysis of Urinary Peptidome Highlights IGF2 Glycopeptides in Association with CKD
por: Lohia, Sonnal, et al.
Publicado: (2023)

CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis
por: Argilés, Àngel, et al.
Publicado: (2013)

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
por: Vanholder, Raymond, et al.
Publicado: (2018)

Collagen-Derived Peptides in CKD: A Link to Fibrosis
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study
por: Neirynck, Nathalie, et al.
Publicado: (2015)

Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population
por: Zhang, Zhen-Yu, et al.
Publicado: (2016)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
por: Boelaert, Jente, et al.
Publicado: (2016)

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
por: Boelaert, Jente, et al.
Publicado: (2016)

The intestine and the kidneys: a bad marriage can be hazardous
por: Vanholder, Raymond, et al.
Publicado: (2015)

Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
por: He, Tianlin, et al.
Publicado: (2020)

Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?
por: Vlahou, Antonia, et al.
Publicado: (2021)

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria
por: Andersen, Sten, et al.
Publicado: (2010)

Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy
por: Krochmal, Magdalena, et al.
Publicado: (2017)

Identification of ageing-associated naturally occurring peptides in human urine
por: Nkuipou-Kenfack, Esther, et al.
Publicado: (2015)

Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease
por: Lygirou, Vasiliki, et al.
Publicado: (2018)

What is new in uremic toxicity?
por: Vanholder, Raymond, et al.
Publicado: (2008)

Left ventricular diastolic function in relation to the urinary proteome: A proof-of-concept study in a general population
por: Zhang, Zhenyu, et al.
Publicado: (2014)

Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure
por: He, Tianlin, et al.
Publicado: (2021)

Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients
por: Eloot, Sunny, et al.
Publicado: (2017)

p-Cresyl Sulfate
por: Gryp, Tessa, et al.
Publicado: (2017)

Development of a MALDI MS‐based platform for early detection of acute kidney injury
por: Carrick, Emma, et al.
Publicado: (2016)

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial
por: Lindhardt, Morten, et al.
Publicado: (2016)

Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)
por: Vanholder, Raymond, et al.
Publicado: (2018)

PeptiCKDdb—peptide- and protein-centric database for the investigation of genesis and progression of chronic kidney disease
por: Krochmal, Magdalena, et al.
Publicado: (2016)

What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
por: Vanholder, Raymond, et al.
Publicado: (2022)

Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease
por: Verbeke, Francis, et al.
Publicado: (2022)

A Urinary Fragment of Mucin-1 Subunit α Is a Novel Biomarker Associated With Renal Dysfunction in the General Population
por: Zhang, Zhen-Yu, et al.
Publicado: (2017)

Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
por: Liabeuf, Sophie, et al.
Publicado: (2013)

Transcriptome Analysis in Patients with Chronic Kidney Disease on Hemodialysis Disclosing a Key Role for CD16(+)CX3CR1(+) Monocytes
por: Schepers, Eva, et al.
Publicado: (2015)

Publisher Correction: Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2018)

Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2018)

Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease
por: Pena, Michelle J., et al.
Publicado: (2016)

Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios
por: Keller, Felix, et al.
Publicado: (2023)

Epidemiologic observations guiding clinical application of a urinary peptidomic marker of diastolic left ventricular dysfunction
por: Zhang, Zhen-Yu, et al.
Publicado: (2018)

Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes
por: Mutsaers, Henricus A. M., et al.
Publicado: (2015)

Looking beyond endotoxin: a comparative study of pyrogen retention by ultrafilters used for the preparation of sterile dialyis fluid
por: Glorieux, Griet, et al.
Publicado: (2014)

Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial
por: Dhondt, Annemieke, et al.
Publicado: (2015)

Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies
por: Vanholder, Raymond, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_d8k8b77ssk5glv9l8h2h852tcb